TipRanks
Advertisement
Advertisement

DE:NV3P Stock Latest News

NanoViricides says Phase II trial of NV-387 in ebola ‘proceeding as designed’
The FlyNanoViricides says Phase II trial of NV-387 in ebola ‘proceeding as designed’
5d ago
NNVC
NanoViricides ‘actively exploring’ additional required funding
PremiumThe Fly
NanoViricides ‘actively exploring’ additional required funding
11d ago
NNVC
NanoViricides reports FY26 EPS (41c) vs. (63c) last year
PremiumThe Fly
NanoViricides reports FY26 EPS (41c) vs. (63c) last year
11d ago
NNVC
NanoViricides says Phase II trial of NV-387 in ebola starts enrollment, dosing
PremiumThe Fly
NanoViricides says Phase II trial of NV-387 in ebola starts enrollment, dosing
12d ago
NNVC
NanoViricides begins Phase II trial of NV-387 in Monkeypox in DRC
PremiumThe Fly
NanoViricides begins Phase II trial of NV-387 in Monkeypox in DRC
17d ago
NNVC
NanoViricides to begin Phase II trial of NV-387 in ebola next week
PremiumThe FlyNanoViricides to begin Phase II trial of NV-387 in ebola next week
25d ago
NNVC
NanoViricides announces registration of Phase II trial of NV-387 in ebolavirus
Premium
The Fly
NanoViricides announces registration of Phase II trial of NV-387 in ebolavirus
1M ago
NNVC
NanoViricides provides updateon Measles Drug Treatment Program
Premium
The Fly
NanoViricides provides updateon Measles Drug Treatment Program
1M ago
NNVC
NanoViricides registers to sell 2.52M shares of common stock for holders
PremiumThe Fly
NanoViricides registers to sell 2.52M shares of common stock for holders
2M ago
NNVC
NanoViricides to begin Phase II trial of NV-387 in ebola ‘soon’
PremiumThe Fly
NanoViricides to begin Phase II trial of NV-387 in ebola ‘soon’
2M ago
NNVC
NanoViricides receives regulatory approval for Phase II trial of NV-387
PremiumThe Fly
NanoViricides receives regulatory approval for Phase II trial of NV-387
2M ago
NNVC
NanoViricides Announces $3.8 Million Registered Direct Offering
PremiumCompany Announcements
NanoViricides Announces $3.8 Million Registered Direct Offering
2M ago
8K
NNVC
NanoViricides awaits regulatory approval to being Phase II trial of NV-387
PremiumThe FlyNanoViricides awaits regulatory approval to being Phase II trial of NV-387
2M ago
NNVC
NanoViricides prices $3.8M registered direct offering
Premium
The Fly
NanoViricides prices $3.8M registered direct offering
3M ago
NNVC
NanoViricides applies for ACOREP approval to begin Phase II NV-387 trial
Premium
The Fly
NanoViricides applies for ACOREP approval to begin Phase II NV-387 trial
3M ago
NNVC
NanoViricides Establishes ATM Equity Sales Agreement
PremiumCompany Announcements
NanoViricides Establishes ATM Equity Sales Agreement
3M ago
8K
NNVC
NanoViricides gets National Ethics Committee approval for Phase II NV-387 trial
PremiumThe Fly
NanoViricides gets National Ethics Committee approval for Phase II NV-387 trial
3M ago
NNVC
NanoViricides initiated with an Outperform at Noble Capital
PremiumThe Fly
NanoViricides initiated with an Outperform at Noble Capital
3M ago
NNVC
NanoViricides advances towards Phase II clinical trial of NV-387
PremiumThe Fly
NanoViricides advances towards Phase II clinical trial of NV-387
3M ago
NNVC
NanoViricides granted Rare Pediatric Disease Drug designation for NV-387
PremiumThe FlyNanoViricides granted Rare Pediatric Disease Drug designation for NV-387
3M ago
NNVC
CDC raises Ebola Congo outbreak response to highest level, Reuters reports
Premium
The Fly
CDC raises Ebola Congo outbreak response to highest level, Reuters reports
4M ago
CODX
GOVX
NanoViricides ships NV-387 oral gummies for Phase II trials to DR Congo
Premium
The Fly
NanoViricides ships NV-387 oral gummies for Phase II trials to DR Congo
4M ago
NNVC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >